Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes

Yilmaz-Aydogan, Hülya; Kurnaz, Özlem; Kucukhuseyin, Özlem; Akadam-Teker, Basak; Kurt, Özlem; Eronat, Allison; Tekeli, Atike; Bugra, Melike; Ozturk, Oğuz

doi:10.1016/j.gene.2013.03.136

Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes

Yilmaz-Aydogan H., Kurnaz Ö., Kucukhuseyin O., Akadam-Teker B., Kurt Ö., Eronat A. P., ...Daha Fazla

GENE, cilt.523, ss.20-26, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 523
Basım Tarihi: 2013
Doi Numarası: 10.1016/j.gene.2013.03.136
Dergi Adı: GENE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.20-26
Anahtar Kelimeler: PPARA, PPARG, APOE, Coronary heart disease, Type 2 diabetes, ACTIVATED RECEPTOR-ALPHA, APOLIPOPROTEIN-E POLYMORPHISM, L162V POLYMORPHISM, GENE, ASSOCIATION, GAMMA, TYPE-2, ATHEROSCLEROSIS, EXPRESSION, VARIANTS
İstanbul Üniversitesi Adresli: Evet

Özet

Background: The aim of this study was to investigate the individual or combined effects of PPARA-L162V, PPARG-C161T and APOE polymorphisms on hyperlipidemia in coronary heart disease (CHD) patients.